Brought to you by:
-
Presenting a united front to address vascular surgery’s structural and financial challenges
Vascular surgeons must present a unified front in order to address structural and financial challenges facing the specialty, Society for Vascular Surgery (SVS) President-Elect Keith Calligaro, MD, said in summing up this year’s E. Stanley Crawford Critical Issues Forum at the 2025 Vascular Annual Meeting (VAM) in New Orleans. This year, the annual forum explored…
-
Three honored in VAM 2025 Poster Competition
The final day of the 2025 Vascular Annual Meeting (VAM) in New Orleans honored three winners in the championship round of the SVS Poster Competition. The audience voted to select the winners from more than 100 entries highlighting innovative research. Hassan Chamseddine, MD, took first place and a $1,500 prize for “Time is intestine: The…
-
ATEV shows promise in high-risk patients on hemodialysis
Results from the CLN-PRO-V007 pivotal phase 3 clinical trial of the acellular tissue engineered vessel (ATEV; Humacyte) in arteriovenous access for patients at high risk of autologous arteriovenous fistula (AVF) maturation failure with end-stage renal disease were presented at the 2025 Vascular Annual Meeting (VAM) in New Orleans (June 4–7). The trial’s results, presented by…
-
Claim CME credits from 2025 vascular meetings
Attendees of the 2025 Vascular Annual Meeting (VAM), Vascular Quality Initiative (VQI) Annual Meeting, and Society of Vascular Nursing (SVN) Annual Conference are reminded to claim their continuing medical education (CME) credits by 10:59 p.m. Central Time on July 7. Participants can secure their credits by logging into the VAM 2025 Online Planner or Mobile…
-
Basic and translational science, Resident Research Award, SVS Foundation, VAM 2025, Vascular Annual Meeting
Award-winning basic science research targets ‘highly complex’ process of vascular calcification
“We were really excited to know that the SVS [Society for Vascular Surgery] is supporting our research,” Sujin Lee, MD, told Vascular Specialist on receiving the SVS Foundation James S.T. Yao Resident Research Award for a paper examining the role of the FNDC1 protein in vascular calcification. Lee, a vascular surgery resident at Massachusetts General Hospital…
-
Increased experience with off-the-shelf TAAA endograft sees reduction in complications but no effect on mortality
Michele Piazza, MD, informed attendees of the 2025 Vascular Annual Meeting (VAM) that increased experience with the E-nside (Artivion) off-the-shelf preloaded inner branch endograft for branched endovascular aneurysm repair (BEVAR) leads to a “significant” reduction in intraprocedural complications, but does not affect early mortality, major adverse event, or midterm results. “The E-nside is an off-the-shelf preloaded…
-
VAM 2025: Crawford Forum probes four reasonable strategies to empower vascular surgeons
“Go back home and get a vascular center or […] get a vascular department, or, you know, assess the compensation [survey] results and, at least start considering a union, if it’s something feasible.” That was the new Society for Vascular Surgery (SVS) President Keith Calligaro’s distillation of the burning issues and strategies to empower vascular surgeons…
-
New THRIVE data on CAVT technology for acute limb ischemia show ‘fewer complications, hospital resource use’
Recent THRIVE study data show that Penumbra’s computer-assisted vacuum thrombectomy (CAVT) technology not only has the potential to improve outcomes for lower extremity acute limb ischemia (LE-ALI) patients, but may also reduce healthcare resource use, thus potentially lowering overall costs for the healthcare system. The latest data were presented at the 2025 Vascular Annual Meeting…
-
SVS announces election results for new leadership
The Society for Vascular Surgery (SVS) has elected Andres Schanzer, MD, as the incoming vice president and Malachi G. Sheahan III, MD, as the new secretary, revealed during Friday night’s Annual Business Meeting, as part of the 2025 Vascular Annual Meeting (June 4-7) in New Orleans. As vice president, Schanzer will help coordinate the activities…
-
Two-year data show continued clinical improvement with VenoValve
Implantation of the VenoValve (enVVeno Medical) continues to promote stabilization of symptoms in patients with deep venous reflux at two-year follow-up. This is the headline finding of data shared yesterday during Plenary Session 6 at VAM 2025. In the abstract outlining their findings, submitting and presenting author Cassius Iyad Ochoa Chaar, MD, associate professor of…